New digital health partners Novo Nordisk and Glooko have released ... manage their diabetes by letting them measure and track their blood glucose, activity and meals all in one place.
Novo Nordisk has made its smart insulin pens available ... to inaccurate or incomplete information that can impact on blood sugar control, says the company. Tighter glucose control is known ...
The US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic (semaglutide) to reduce certain risks ...
The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.